Search Results

Medical device company Linear Health Sciences today announced multiple clinical and commercial milestones for its Orchid SRV™ , a breakaway safety valve designed to improve the use of medical tubing in hospitals.

Linear Health Sciences announced the publication of a new whitepaper on accidental dislodgement of IV catheter lines.

Linear Health Sciences has been awarded a national group purchasing agreement for the IV Therapy - Needleless Connectors category with Premier, Inc. Effective Jan. 1, 2024, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the Orchid SRV force-activated separation device.

Medical device company Linear Health Sciences announced it received an expanded indication from the U.S. Food & Drug Administration for its Orchid SRV™ safety release valve.

Medical device company Linear Health Sciences today advanced the commercialization of its Orchid SRV ™ tension-activated breakaway safety release valve, announcing the appointment of Rob Headley as vice president of sales and business development, and Jessica Czamanski as director of product and regulatory affairs.

Medical device company Linear Health Sciences announced it received an expanded indication from the U.S. Food & Drug Administration for its Orchid SRV™, a tension-activated breakaway safety release valve designed to reduce the risk of IV catheter failure and replacement in hospitals.

Seres Therapeutics, Inc., announced that it has agreed to a non-binding memorandum of understanding with Nestlé Health Science in which Nestlé Health Science will acquire certain tangible and intangible assets associated with VOWST capsules.

Linear Health Sciences Receives Innovative Technology Contract from Vizient for Orchid SRV IV Safety Device.

Seres Therapeutics, Inc., a leading microbiome therapeutics company, announced that it has entered into a non-binding memorandum of understanding with Nestlé Health Science for the sale of Seres’ VOWST assets that will provide Nestlé Health Science with full VOWST product and related intellectual property rights.

On this episode of Denatured, Lori Ellis and guests discuss President Biden’s Executive Order on Advancing Women’s Health Research and Innovation and the outlook of investment in women’s health.